US Broker Ratings

Novo Nordisk A/S (NVO) Stock Analysis: Exploring Growth Potential Amid Robust Revenue Gains

Investors eyeing opportunities in the healthcare sector should pay close attention to Novo Nordisk A/S (NVO), a Danish pharmaceutical giant with a commanding presence in diabetes and obesity care. With..

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Giant’s 5.99% Upside Potential Captivates Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable name in the global healthcare sector, showcasing a robust market capitalization of $302.33 billion. As one of the prominent players..

Regeneron Pharmaceuticals, Inc. (REGN): Analyst Ratings Signal Strong Buy with 30% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology industry, has been capturing the attention of investors with a promising 30.43% potential upside. With its current price at $638.88,..

ResMed Inc. (RMD) Stock Analysis: Robust Growth Potential Amidst Healthcare Innovations

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, has been making significant strides in the medical instruments and supplies industry. With a market capitalization of $30.18 billion, ResMed..

McKesson Corporation (MCK) Stock Analysis: Exploring a 23.97% Potential Upside and Solid Growth Prospects

Investors looking to diversify their portfolios with a robust player in the healthcare sector might find McKesson Corporation (NYSE: MCK) a compelling choice. With a commanding market capitalization of $92.09..

Novartis AG (NVS) Stock Analysis: Strong ROE and Strategic Focus Positioning for Growth

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, specifically within the drug manufacturing industry, has once again caught the eye of investors with its robust financial metrics..

AbbVie Inc. (ABBV) Stock Analysis: Unraveling a 17% Potential Upside Amid Robust Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector specializing in drug manufacturing, has captured investor attention with a notable 17.24% potential upside. The biopharmaceutical giant, with a market..

Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, Inspire Medical has carved out..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is attracting attention from investors with its focus on developing innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. With a market capitalization of..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 103% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, is gaining attention for its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with 10.83% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a notable player within the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. With a market capitalization of $6.11..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 6.19% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates in the specialized and generic drug manufacturing industry. With a market capitalization of $19.19 billion, Viatris has established..

Soleno Therapeutics, Inc. (SLNO) Stock Report: A Biotech Player with Steady ROE and Strategic Focus on Rare Diseases

Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands out in the biotechnology sector with its strategic focus on treating rare diseases. With a market capitalization of $2.76 billion, this Redwood City-based company..

Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation

Bio-Techne Corporation (NASDAQ: TECH), a pioneering entity in the biotechnology arena, offers investors a fascinating opportunity with a significant potential upside of 41.84%. As a key player in the healthcare..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a titan in the medical distribution sector, stands as a compelling choice for investors looking to tap into the healthcare industry. With a market capitalization..

Cytokinetics, Incorporated (CYTK): Investor Outlook with a 38% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, capturing investor attention with its innovative approach to treating muscle-related diseases. Headquartered in South San Francisco, California, this..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and Promising 5.38% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS), a Pittsburgh-based player in the biotechnology sector, is making significant waves in the healthcare industry with its genetic medicines targeting diseases with high unmet needs...

West Pharmaceutical Services (WST) Stock Analysis: Strong Growth Potential with a 15.5% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, commands significant attention from investors due to its robust market presence and promising growth trajectory. This Exton,..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and Promising Growth in Healthcare

BrightSpring Health Services, Inc. (BTSG) is emerging as a compelling investment opportunity in the Health Information Services industry, driven by robust buy ratings and impressive revenue growth. Headquartered in Louisville,..

Masimo Corporation (MASI) Stock Analysis: A Look at Revenue Growth and Robust Returns

As an investor with a focus on healthcare and medical devices, Masimo Corporation (NASDAQ: MASI) represents a noteworthy opportunity, particularly given its impressive revenue growth and robust return on equity...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds